Sebastiano B. Solerte
Pavia, 27100, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Suitability and Usefulness of a Flexible Dosing Timing of Oral Semaglutide to Maximize Benefit in Clinical Practice: An Expert Panel.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: May 23, 2024
Diabulimia and Type 1 Diabetes: An Unknown and Emerging Problem.
Journal: Endocrine, metabolic & immune disorders drug targets
Published: March 06, 2024
Real world effectiveness of subcutaneous semaglutide in type 2 diabetes: A retrospective, cohort study (Sema-MiDiab01).
Journal: Frontiers in endocrinology
Published: November 15, 2022
Reply to letter to the editor regarding "Use of DPP-4 inhibitors in patients with COVID-19".
Journal: Acta diabetologica
Published: October 23, 2020
Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19.
Journal: Acta diabetologica
Published: April 09, 2020
Clinical efficacy and predictors of response to dulaglutide in type-2 diabetes.
Journal: Pharmacological research
Published: March 30, 2020
Efficacy of SGLT-2 inhibitors in older adults with diabetes: Systematic review with meta-analysis of cardiovascular outcome trials.
Journal: Diabetes research and clinical practice
Published: February 11, 2020
12-month effects of incretins versus SGLT2-Inhibitors on cognitive performance and metabolic profile. A randomized clinical trial in the elderly with Type-2 diabetes mellitus.
Journal: Clinical pharmacology : advances and applications
Published: October 24, 2018
Last Updated: 09/26/2026